Soluble endothelial and platelet selectins in serum and ascitic fluid of women with ovarian hyperstimulation syndrome

American Journal of Reproductive Immunology

Volumn 45, Issue 3, 2001, Pages 154-160

  Daniel, Yair ^a,b,c   Geva, Eli ^a,b   Amit, Ami ^a,b   Eshed Englender, Talma ^b   Bar Am, Amiram ^a,b   Lessing, Joseph B ^a,b  

^a LIS MATERNITY HOSPITAL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c NONE   (Israel)

Author keywords

Angiogenesis; Cell adhesion molecules; Cytokines; Inflammation; Ovulation induction

Indexed keywords

BUSERELIN ACETATE; CELL ADHESION MOLECULE; CHORIONIC GONADOTROPIN; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HUMAN MENOPAUSAL GONADOTROPIN; NOSE SPRAY; PADGEM PROTEIN;

ADULT; ANGIOGENESIS; ARTICLE; ASCITES FLUID LEVEL; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; IMMUNE RESPONSE; INFLAMMATION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PERITONEAL FLUID; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

EID: 0035131341     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.8755-8920.2001.450306.x     Document Type: Article

References (10)

1. Golan A, Ron-El R, Herman A, Soffer Y, Weinraub Z, Caspi E: Ovarian hyperstimulation syndrome: An update review. Obstet Gynecol Surv 1989; 44:430-440.
2. Navot D, Bergh PA, Laufer N: Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment. Fertil Steril 1992; 58:249-261.
3. Geva E, Amit A, Lerner-Geva L, Lessing JB: Ovarian hyperstimulation syndrome: The role of cytokines. Assist Reprod Rev 1997; 7:1168-1173.
4. Revel A, Barak V, Lavy Y, Anteby E, Abramov Y, Shenker JJ, Amit A, Finci-Yeheskel Z, Mayer M, Simon A, Laufer N, Hurwitz A: Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertil Steril 1996; 66:66-71.
5. Loret de Mola JR, Baumgardner GP, Goldfarb JM, Friedlander MA: Ovarian hyperstimulation syndrome: Pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-alpha cannot predict its occurrence. Hum Reprod 1996; 11:1377-1380.
6. Ben-Rafael Z, Orvieto R: Cytokines-involvement in reproduction. Fertil Steril 1992; 58:1093-1099.
7. Friedlander MA, Loret de Mola JR, Goldfarb JM: Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome. Fertil Steril 1993; 60:826-833.
8. Abramov Y, Schenker JG, Lewin A, Friedlender S, Nisman B, Barak V: Plasma inflammatory cytokins correlate to the ovarian hyperstimulation syndrome. Hum Reprod 1996; 11:1381-1386.
9. McClure N, Healy DL, Rogers PA, Sullivan J, Beaton L, Haning RV, Connolly DT, Robertson DM: Vascular endothelial growth factor as capillary permeability agent in Ovarian hyperstimulation syndrome. Lancet 1994; 344:235-236.
10. Abramov Y, Barak V, Nisman B, Schenker JG: Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 1997; 68:133-137.